Kiniksa Pharmaceuticals International, plc Accounts Payable
Kiniksa Pharmaceuticals International, plc (KNSA) had Accounts Payable of $24.40 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-04-28
- 2026-03-31: Accounts Payable, Current $24.40M.
- 2025-12-31: Accounts Payable, Current $2.03M.
- 2025-09-30: Accounts Payable, Current $6.15M.
- 2025-06-30: Accounts Payable, Current $8.96M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-03-31 | $24.40M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $2.03M 10-Q · filed 2026-04-28 |
| 2025-09-30 | $6.15M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $8.96M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $1.98M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $2.04M 10-K · filed 2026-02-24 |
| 2024-09-30 | $8.33M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $7.39M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $5.63M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $8.25M 10-K · filed 2025-02-25 |
| 2023-09-30 | $1.01M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $648.00K 10-Q · filed 2023-08-01 |
| 2023-03-31 | $1.39M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $7.90M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.47M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.52M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.38M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.87M 10-K · filed 2023-03-02 |
| 2021-09-30 | $1.65M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $4.16M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.76M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $503.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $3.92M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.37M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $4.27M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $5.69M 10-K · filed 2021-02-25 |
| 2019-09-30 | $6.44M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $9.34M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $6.89M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $10.92M 10-K · filed 2020-03-05 |
| 2018-09-30 | $4.67M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $561.00K 10-Q · filed 2018-08-06 |
| 2017-12-31 | $1.22M 10-K · filed 2019-03-12 |